Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
30.06.23
/
50%
€12.81
Target price
30.06.24
€15.60
Performance (%)
-90.29%
End price
01.07.24
€1.24
Summary
This prediction ended on 01.07.24 with a price of €1.24. The BUY prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc. performed very badly with a performance of -90.29%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | -4.492% | -4.492% | 10.340% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.26
10.04.24
10.04.24
€6.50
10.04.25
10.04.25
-62.31%
11.04.25
11.04.25
